Ignite Creation Date:
2024-05-06 @ 3:56 PM
Last Modification Date:
2024-10-26 @ 2:00 PM
Study NCT ID:
NCT04812067
Status:
COMPLETED
Last Update Posted:
2023-11-07
First Post:
2021-03-19
Brief Title:
A Safety and Efficacy Trial of TTHX1114 in People With CED
Sponsor:
Trefoil Therapeutics Inc
Organization:
Trefoil Therapeutics Inc
Study Overview
Official Title:
A Phase 2 Clinical Trial to Assess the Safety and Observe the Potential Benefit of TTHX1114 Delivered Via Intra-Cameral IC Injection
Status:
COMPLETED
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
OPTIC
Brief Summary:
Expanded access open label study at a single dose level in patients with CED that in the opinion of the investigators might benefit from TTHX1114
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None